As 2025 draws to a close and publicly offered funds start rolling out their fourth-quarter reports, a clear picture is emerging regarding how top-performing funds have been adjusting their portfolios. Broadly speaking, these funds have maintained sizable positions and are mainly reallocating assets toward high-growth sectors. These include the AI industry chain, innovative pharmaceuticals, and robotics—areas brimming with potential and promise. When it comes to the AI sector, fund managers have not only kept their holdings but have also taken steps to refine and optimize their investment targets, ensuring they stay ahead of the curve.
